Based on the data, I would recommend a BUY.

Here's why:

* The forward PE is significantly lower than the trailing PE, indicating that the market expects the company's earnings to increase significantly in the coming periods.
* The ROE and profit margin are reasonable, indicating that the company is generating decent profits from its operations.
* The revenue and earnings growth rates are both positive, indicating that the company is expanding its business.
* The debt-to-equity ratio is manageable, suggesting that the company has a relatively stable financial position.

Overall, the combination of strong growth prospects, reasonable profitability, and manageable debt makes Dr. Reddy's Laboratories Limited an attractive investment opportunity.